Head of Cancer Epigenetics team;
Main research activities:
I. Investigation of epigenetic mechanisms involved in tumorigenesis
II. Identification and characterization of new epigenetic modulators
III. Investigation of mechanisms by which epigenetic modulators induce anti-tumor activities for preventive and therapeutic purposes
...
Michael Schnekenburger
Team leader of “Cancer epigenetics” research group
Summary
Published articles Show More
4-Hydroxybenzoic acid derivatives as HDAC6-specific inhibitors modulating microtubular structure and HSP90a chaperone ac...
Published in Biochemical Pharmacology in Jan 02, 2016
Histone deacetylase (HDAC)6 is a unique isoenzyme targeting specific substrates including a-tubulin and heat shock protein (HSP)90. HDAC6 is involved in protein trafficking and degradation, cell shape and migration. Deregulation of HDAC6 activity is associated with a variety of diseases including cancer leading to a growing interest for developing ...
Dual Induction of Mitochondrial Apoptosis and Senescence in Chronic Myelogenous Leukemia by Myrtucommulone A
Published in Anti-Cancer Agents in Medicinal Chemistry in Jan 11, 2015
Despite recent advances in the treatment of chronic myelogenous leukemia (CML), the development of drug resistance and minimal residual disease remain major challenges for the treatment of CML patients, thus highlighting the need to develop innovative new approaches to improve therapeutic outcome. Myrtucommulone A (MCA) is a nonprenylated acylphlor...
Plant-derived epigenetic modulators for cancer treatment and prevention
Published in Biotechnology Advances
Carcinogenesis is a complex and multistep process that involves the accumulation of successive transformational events driven by genetic mutations and epigenetic alterations that affect major cellular processes and pathways such as proliferation, differentiation, invasion and survival. Massive deregulation of all components of the epigenetic machin...
Experience
Team leader of “Cancer epigenetics” research group Since August 2007
Laboratoire de Biologie Moléculaire et Cellulaire du Cancer (LBMCC) (Luxembourg LU)
Role, mechanisms and therapeutic potential of epigenetics in cancer
Post-doctoral fellow April 2005 - July 2007
University of Cincinnati (Cincinnati US)
Department of Environmental Health
PhD student November 2001 - March 2005
Laboratoire de Biologie Moléculaire et Cellulaire du Cancer (LBMCC) (Luxembourg LU)
Recipient of a grant from the Luxembourgish government
Internship September 2000 - August 2001
University of Reims Champagne-Ardenne (Reims FR)
Laboratoire de Spectroscopie Biomoléculaire; Unité MéDian, CNRS FRE 2141, IFR 53, Faculty of Pharmacy
Internship November 1999 - April 2000
University of Reims Champagne-Ardenne (Reims FR)
Laboratory of parasitology
Education
PhD September 2001 - December 2004
University of Reims Champagne-Ardenne (Reims FR)
PhD thesis in molecular and cellular biology
MSc September 1999 - July 2001
University of Reims Champagne-Ardenne (Reims FR)
Biochemistry; 1st year: Faculty of Sciences, 2nd year: Faculty of Pharmacy
BSc September 1997 - July 1999
University of Reims Champagne-Ardenne (Reims FR)
Life sciences-Biochemistry; Faculty of Sciences
Awards
Poster presentation award May 2006
Post-doctoral scholars research forum (Cincinnati, Ohio, USA)
PhD scholarship November 2001
From the Ministry for Higher Education and Research in Luxembourg (2001-2004)
Interests
Contact me
0000-0003-0550-9538